JPWO2024237214A5 - - Google Patents
Info
- Publication number
- JPWO2024237214A5 JPWO2024237214A5 JP2025520569A JP2025520569A JPWO2024237214A5 JP WO2024237214 A5 JPWO2024237214 A5 JP WO2024237214A5 JP 2025520569 A JP2025520569 A JP 2025520569A JP 2025520569 A JP2025520569 A JP 2025520569A JP WO2024237214 A5 JPWO2024237214 A5 JP WO2024237214A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- nucleic acid
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023079064 | 2023-05-12 | ||
| PCT/JP2024/017517 WO2024237214A1 (ja) | 2023-05-12 | 2024-05-10 | 脂質複合体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2024237214A1 JPWO2024237214A1 (https=) | 2024-11-21 |
| JPWO2024237214A5 true JPWO2024237214A5 (https=) | 2026-02-12 |
Family
ID=93519719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025520569A Pending JPWO2024237214A1 (https=) | 2023-05-12 | 2024-05-10 |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4711463A1 (https=) |
| JP (1) | JPWO2024237214A1 (https=) |
| WO (1) | WO2024237214A1 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030091592A1 (en) * | 2001-10-09 | 2003-05-15 | Barber Glen N. | Generation of virus-like particles by VSV |
| EP3093283B1 (en) | 2014-01-09 | 2018-12-19 | Eisai R&D Management Co., Ltd. | Cationic lipid |
| US10081598B2 (en) | 2014-12-26 | 2018-09-25 | Eisai R&D Management Co., Ltd. | Cationic lipid |
| WO2017222016A1 (ja) | 2016-06-24 | 2017-12-28 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | カチオン性脂質 |
| EP3733647B1 (en) | 2017-12-27 | 2022-06-15 | Eisai R&D Management Co., Ltd. | Cationic lipid |
| JPWO2022244801A1 (https=) * | 2021-05-19 | 2022-11-24 | ||
| WO2023220645A1 (en) * | 2022-05-10 | 2023-11-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Vaccine for human t-lymphotropic virus-1 |
-
2024
- 2024-05-10 JP JP2025520569A patent/JPWO2024237214A1/ja active Pending
- 2024-05-10 WO PCT/JP2024/017517 patent/WO2024237214A1/ja not_active Ceased
- 2024-05-10 EP EP24807166.4A patent/EP4711463A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5656611A (en) | Polynucleotide compositions | |
| TWI868509B (zh) | 用於B型肝炎病毒感染之RNAi藥劑 | |
| JP7430713B2 (ja) | 核酸送達のための脂質化カチオン性ペプチド化合物を含む脂質ナノ粒子製剤 | |
| EP0527906B1 (en) | Inhibition of influenza virus replication by oligonucleotides | |
| JP6715325B2 (ja) | siRNA、siRNAを含む医薬組成物及び結合体、並びにそれらの応用 | |
| JP2024099745A5 (https=) | ||
| TWI872048B (zh) | 用於B型肝炎病毒感染之RNAi劑 | |
| JP6752151B2 (ja) | 遺伝子サイレンシングにおいて低下したoff−target効果を有するunaオリゴマー | |
| CN105451743B (zh) | 用于在活体中递送RNAi触发子至肿瘤细胞的聚偶联物 | |
| JP2024533312A5 (https=) | ||
| JPH10510435A (ja) | B型肝炎ウイルス複製のアンチセンス阻害 | |
| JP2024533313A5 (https=) | ||
| PT850300E (pt) | Metodo de modulacao da expressao de genes com resposta imunoestimulante reduzida | |
| WO1996032474A1 (en) | Cooperative oligonucleotides | |
| JP2024524291A5 (https=) | ||
| JP2017517253A (ja) | ペプチド担体上の多重オリゴヌクレオチド部分 | |
| US5637573A (en) | Influenza virus replication inhibiting oligonucleotide analogues and their pharmaceutical compositions | |
| JP2024534786A5 (https=) | ||
| JPWO2024237214A5 (https=) | ||
| JP5613050B2 (ja) | タンパク質−高分子結合体 | |
| JP2024532464A5 (https=) | ||
| JP2024518710A5 (https=) | ||
| JP2001151697A (ja) | 新規ワクチン組成物及び界面活性剤の免疫用アジュバントとしての使用 | |
| US20240182898A1 (en) | ENHANCED OLIGONUCLEOTIDES FOR INHIBITING RTELl EXPRESSION | |
| WO1997038097A1 (en) | Cooperative oligonucleotides |